Fresenius

Investment Overview

Investment Highlights

• Essential Healthcare Tenant – Fresenius is a global leader in kidney dialysis care providing critical, recurring medical services with durable long-term demand.
• Recently Exercised Early Renewal – Tenant has demonstrated commitment to the location by exercising an early renewal option, leaving 7+ years remaining through June 2033.
• On-site Manager Handling Maintenance Items for Property - Given Strict Medical Protocols and Minimized Tenant Disruption
• Built-In Rent Growth – Lease includes 2% annual rental increases throughout the base term and renewal options, creating consistent NOI growth.
• Strong Lease Guaranty – Lease is guaranteed by Bio-Medical Applications of Georgia, Inc., an affiliate of Fresenius Medical Care.
• Attractive NN Lease Structure – Tenant is responsible for taxes, CAM, insurance, roof, and structure, minimizing landlord obligations.
• Established Medical Facility – 5,980 SF dialysis center situated on a 1.09-acre parcel, purpose-built for healthcare operations with established patient infrastructure.
• Recession Resistant Asset Class – Dialysis treatment is a non-discretionary healthcare service, providing defensive cash flow characteristics compared to traditional retail assets.
• Regional Hub Location – Located in Waycross, a major Southeast Georgia transportation and healthcare hub serving a broad regional trade area.